Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
2,149,205
-
Shares change
-
+769
-
Total reported value, excl. options
-
$44,080,900
-
Value change
-
+$15,101
-
Number of buys
-
24
-
Number of sells
-
-17
-
Price
-
$20.51
Significant Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q2 2025
54 filings reported holding IDNA - ISHARES TR - GENOMICS IMMUN as of Q2 2025.
ISHARES TR - GENOMICS IMMUN (IDNA) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,149,205 shares
.
Largest 10 shareholders include UBS Group AG (552,343 shares), Wharton Business Group, LLC (290,727 shares), BANK OF AMERICA CORP /DE/ (270,121 shares), RAYMOND JAMES FINANCIAL INC (135,555 shares), MORGAN STANLEY (131,644 shares), Portland Global Advisors LLC (102,323 shares), Royal Bank of Canada (74,101 shares), Clearwater Capital Advisors, LLC (67,128 shares), AMERIPRISE FINANCIAL INC (65,933 shares), and LPL Financial LLC (46,533 shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.